WNT5B and cancer: Strikingly, cancer cell migration increased as a result of DNMT3A-3 L targeting, but decreased by TET1 targeting or overexpression of WNT5B complementary DNA (cDNA) (Fig. 3b and Additional file 1: Figure S9).